Advertisement
Screener

Concert Pharmaceuticals, Inc. Operating Income

Concert Pharmaceuticals, Inc. Operating Income

Concert Pharmaceuticals, Inc. reported Operating Income of -$29.61 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-07.

Discontinued › Income Statement

us-gaap:OperatingIncomeLoss · last filed 2022-11-07

  • Concert Pharmaceuticals, Inc. operating income (loss) for the quarter ending 2022-09-30 was -$29.61M.
  • Concert Pharmaceuticals, Inc. operating income (loss) for the quarter ending 2022-06-30 was -$25.68M, a 512.98% decline year-over-year.
  • Concert Pharmaceuticals, Inc. operating income (loss) for the quarter ending 2022-03-31 was -$36.03M.
  • Concert Pharmaceuticals, Inc. operating income (loss) for the quarter ending 2021-12-31 was -$32.95M.
  • Concert Pharmaceuticals, Inc. operating income (loss) for fiscal 2021 was -$77.51M.
  • Concert Pharmaceuticals, Inc. operating income (loss) for fiscal 2020 was -$72.65M.
  • Concert Pharmaceuticals, Inc. operating income (loss) for fiscal 2019 was -$79.02M.
  • Concert Pharmaceuticals, Inc. operating income (loss) for fiscal 2018 was -$55.58M, a 159.99% decline from fiscal 2017.
Period endOperating Income (Loss) 3 monthOperating Income (Loss) 6 monthOperating Income (Loss) 9 monthOperating Income (Loss) 12 month
2022-09-30-$29.61M
10-Q · filed 2022-11-07
-$55.29M
derived: sum of 2 quarters · filed 2022-11-07
-$91.32M
10-Q · filed 2022-11-07
-$124.27M
derived: sum of 4 quarters · filed 2022-11-07
2022-06-30-$25.68M
10-Q · filed 2022-08-04
-$61.71M
10-Q · filed 2022-08-04
-$94.66M
derived: sum of 3 quarters · filed 2022-08-04
-$121.46M
derived: sum of 4 quarters · filed 2022-11-07
2022-03-31-$36.03M
10-Q · filed 2022-05-05
-$68.98M
derived: sum of 2 quarters · filed 2022-05-05
-$95.78M
derived: sum of 3 quarters · filed 2022-11-07
-$89.56M
derived: sum of 4 quarters · filed 2022-11-07
2021-12-31-$32.95M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03
-$59.75M
derived: sum of 2 quarters · filed 2022-11-07
-$53.53M
derived: sum of 3 quarters · filed 2022-11-07
-$77.51M
10-K · filed 2022-03-03
2021-09-30-$26.80M
10-Q · filed 2022-11-07
-$20.58M
derived: sum of 2 quarters · filed 2022-11-07
-$44.56M
10-Q · filed 2022-11-07
-$66.06M
derived: sum of 4 quarters · filed 2022-11-07
2021-06-30$6.22M
10-Q · filed 2022-08-04
-$17.76M
10-Q · filed 2022-08-04
-$39.27M
derived: sum of 3 quarters · filed 2022-08-04
-$58.63M
derived: sum of 4 quarters · filed 2022-08-04
2021-03-31-$23.98M
10-Q · filed 2022-05-05
-$45.48M
derived: sum of 2 quarters · filed 2022-05-05
-$64.84M
derived: sum of 3 quarters · filed 2022-05-05
-$77.98M
derived: sum of 4 quarters · filed 2022-05-05
2020-12-31-$21.50M
10-K · filed 2021-02-25
-$40.86M
derived: sum of 2 quarters · filed 2021-11-09
-$54.00M
derived: sum of 3 quarters · filed 2021-11-09
-$72.65M
10-K · filed 2022-03-03
2020-09-30-$19.36M
10-Q · filed 2021-11-09
-$32.49M
derived: sum of 2 quarters · filed 2021-11-09
-$51.14M
10-Q · filed 2021-11-09
-$72.10M
derived: sum of 4 quarters · filed 2021-11-09
2020-06-30-$13.13M
10-Q · filed 2021-08-05
-$31.78M
10-Q · filed 2021-08-05
-$52.74M
derived: sum of 3 quarters · filed 2021-08-05
-$70.98M
derived: sum of 4 quarters · filed 2021-08-05
2020-03-31-$18.65M
10-Q · filed 2021-05-04
-$39.60M
derived: sum of 2 quarters · filed 2021-05-04
-$57.85M
derived: sum of 3 quarters · filed 2021-05-04
-$77.27M
derived: sum of 4 quarters · filed 2021-05-04
2019-12-31-$20.95M
10-K · filed 2021-02-25
-$39.20M
derived: sum of 2 quarters · filed 2021-02-25
-$58.62M
derived: sum of 3 quarters · filed 2021-02-25
-$79.02M
10-K · filed 2021-02-25
2019-09-30-$18.24M
10-K · filed 2021-02-25
-$37.67M
derived: sum of 2 quarters · filed 2021-02-25
-$58.06M
10-Q · filed 2020-11-05
-$78.13M
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30-$19.43M
10-K · filed 2021-02-25
-$39.82M
10-Q · filed 2020-08-06
-$59.88M
derived: sum of 3 quarters · filed 2021-02-25
-$77.22M
derived: sum of 4 quarters · filed 2021-02-25
2019-03-31-$20.39M
10-K · filed 2021-02-25
-$40.46M
derived: sum of 2 quarters · filed 2021-02-25
-$57.80M
derived: sum of 3 quarters · filed 2021-02-25
-$72.17M
derived: sum of 4 quarters · filed 2021-02-25
2018-12-31-$20.06M
10-K · filed 2020-02-27
-$37.40M
derived: sum of 2 quarters · filed 2020-02-27
-$51.78M
derived: sum of 3 quarters · filed 2020-02-27
-$55.58M
10-K · filed 2020-02-27
2018-09-30-$17.34M
10-K · filed 2020-02-27
-$31.71M
derived: sum of 2 quarters · filed 2020-02-27
-$35.52M
10-Q · filed 2019-11-07
-$48.26M
derived: sum of 4 quarters · filed 2020-02-27
2018-06-30-$14.37M
10-K · filed 2020-02-27
-$18.18M
10-Q · filed 2019-08-01
-$30.92M
derived: sum of 3 quarters · filed 2020-02-27
$100.92M
derived: sum of 4 quarters · filed 2020-02-27
2018-03-31-$3.81M
10-K · filed 2020-02-27
-$16.54M
derived: sum of 2 quarters · filed 2020-02-27
$115.29M
derived: sum of 3 quarters · filed 2020-02-27
$102.31M
derived: sum of 4 quarters · filed 2020-02-27
2017-12-31-$12.74M
10-K · filed 2019-02-28
$119.10M
derived: sum of 2 quarters · filed 2019-02-28
$106.12M
derived: sum of 3 quarters · filed 2019-02-28
$92.65M
10-K · filed 2019-02-28
2017-09-30$131.83M
10-K · filed 2019-02-28
$118.86M
derived: sum of 2 quarters · filed 2019-02-28
$105.39M
10-Q · filed 2018-11-01
$93.23M
derived: sum of 4 quarters · filed 2019-02-28
2017-06-30-$12.98M
10-K · filed 2019-02-28
-$26.45M
10-Q · filed 2018-08-02
-$38.60M
derived: sum of 3 quarters · filed 2019-02-28
-$50.07M
derived: sum of 4 quarters · filed 2019-02-28
2017-03-31-$13.47M
10-K · filed 2019-02-28
-$25.62M
derived: sum of 2 quarters · filed 2019-02-28
-$37.09M
derived: sum of 3 quarters · filed 2019-02-28
-$50.66M
derived: sum of 4 quarters · filed 2019-02-28
2016-12-31-$12.15M
10-K · filed 2018-03-01
-$23.62M
derived: sum of 2 quarters · filed 2018-03-01
-$37.19M
derived: sum of 3 quarters · filed 2018-03-01
-$51.17M
10-K · filed 2019-02-28
2016-09-30-$11.47M
10-K · filed 2018-03-01
-$25.04M
derived: sum of 2 quarters · filed 2018-03-01
-$39.02M
10-Q · filed 2017-11-09
-$38.35M
derived: sum of 4 quarters · filed 2018-03-01
2016-06-30-$13.57M
10-K · filed 2018-03-01
-$27.55M
10-Q · filed 2017-08-08
-$26.88M
derived: sum of 3 quarters · filed 2018-03-01
-$35.58M
derived: sum of 4 quarters · filed 2018-03-01
2016-03-31-$13.97M
10-K · filed 2018-03-01
-$13.31M
derived: sum of 2 quarters · filed 2018-03-01
-$22.00M
derived: sum of 3 quarters · filed 2018-03-01
$19.68M
derived: sum of 4 quarters · filed 2018-03-01
2015-12-31$663.00K
10-K · filed 2017-03-06
-$8.03M
derived: sum of 2 quarters · filed 2017-03-06
$33.66M
derived: sum of 3 quarters · filed 2017-03-06
$24.79M
10-K · filed 2018-03-01
2015-09-30-$8.69M
10-K · filed 2017-03-06
$33.00M
derived: sum of 2 quarters · filed 2017-03-06
$24.13M
10-Q · filed 2016-11-08
$15.38M
derived: sum of 4 quarters · filed 2017-03-06
2015-06-30$41.69M
10-K · filed 2017-03-06
$32.82M
10-Q · filed 2016-08-09
$24.07M
derived: sum of 3 quarters · filed 2017-03-06
$16.47M
derived: sum of 4 quarters · filed 2017-03-06
2015-03-31-$8.87M
10-K · filed 2017-03-06
-$17.62M
derived: sum of 2 quarters · filed 2017-03-06
-$25.22M
derived: sum of 3 quarters · filed 2017-03-06
-$32.95M
derived: sum of 4 quarters · filed 2017-03-06
2014-12-31-$8.74M
10-K · filed 2016-03-01
-$16.35M
derived: sum of 2 quarters · filed 2016-03-01
-$24.08M
derived: sum of 3 quarters · filed 2016-03-01
-$30.60M
10-K · filed 2017-03-06
2014-09-30-$7.61M
10-K · filed 2016-03-01
-$15.33M
derived: sum of 2 quarters · filed 2016-03-01
-$21.85M
10-Q · filed 2015-11-05
-$27.43M
derived: sum of 4 quarters · filed 2016-03-01
2014-06-30-$7.73M
10-K · filed 2016-03-01
-$14.24M
10-Q · filed 2015-08-05
-$19.82M
derived: sum of 3 quarters · filed 2016-03-01
-$26.94M
derived: sum of 4 quarters · filed 2016-03-01
2014-03-31-$6.52M
10-K · filed 2016-03-01
-$12.10M
derived: sum of 2 quarters · filed 2016-03-01
-$19.21M
derived: sum of 3 quarters · filed 2016-03-01
-$9.80M
derived: sum of 4 quarters · filed 2016-03-01
2013-12-31-$5.58M
10-K · filed 2015-03-02
-$12.70M
derived: sum of 2 quarters · filed 2015-03-02
-$3.28M
derived: sum of 3 quarters · filed 2015-03-02
-$4.41M
10-K · filed 2016-03-01
2013-09-30-$7.12M
10-K · filed 2015-03-02
$2.30M
derived: sum of 2 quarters · filed 2015-03-02
$1.17M
10-Q · filed 2014-11-12
2013-06-30$9.41M
10-K · filed 2015-03-02
$8.29M
10-Q · filed 2014-08-12
2013-03-31-$1.13M
10-K · filed 2015-03-02
2012-12-31-$18.61M
10-K · filed 2015-03-02